Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Global developmental delay; and very common findings: Spastic tetraplegia. 27 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 13 | Bilateral tonic-clonic seizure, Dystonia, Seizure |
AFG2B encodes AAA ATPase AFG2B (753 aa). ATP-dependent chaperone part of the 55LCC heterohexameric ATPase complex which is chromatin-associated and promotes replisome proteostasis to maintain replication fork progression and genome stability. Highest expression in Skin Sun Exposed Lower leg (16.9 TPM) and Cells EBV-transformed lymphocytes (16.2 TPM).
Neurodevelopmental disorder with hearing loss and spasticity is associated with mutations in the AFG2B gene on chromosome 15.
AFG2B is classified as a druggable target with score 0.0.
Genetic testing for AFG2B is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 1 very common feature, 7 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for neurodevelopmental disorder with hearing loss and spasticity.
10 publications have been identified in PubMed for neurodevelopmental disorder with hearing loss and spasticity. Research spans Case Report / Case Series (38%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (25%).
Nou-Fontanet L (2026). [PMID: 41933351](https://pubmed.ncbi.nlm.nih.gov/41933351/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Albokhari D (2026). [PMID: 42079399](https://pubmed.ncbi.nlm.nih.gov/42079399/). *Mol Genet Metab Rep*. [Case Report / Case Series]
Polczyk A (2025). [PMID: 41375745](https://pubmed.ncbi.nlm.nih.gov/41375745/). *J Clin Med*. [Case Report / Case Series]
Yuan J (2025). [PMID: 41469542](https://pubmed.ncbi.nlm.nih.gov/41469542/). *J Neurodev Disord*. [Epidemiology / Natural History]
Ni C (2025). [PMID: 40760247](https://pubmed.ncbi.nlm.nih.gov/40760247/). *Nat Cell Biol*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 9:21 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
3 |
High palate, Thick upper lip vermilion, Microcephaly |
Muscles | 1 | Low muscle tone (hypotonia) |
Eyes | 1 | Cerebral visual impairment |
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
Dantam CR (2025). [PMID: 40760574](https://pubmed.ncbi.nlm.nih.gov/40760574/). *Medicine (Baltimore)*. [Case Report / Case Series]
Falabella M (2025). [PMID: 39279645](https://pubmed.ncbi.nlm.nih.gov/39279645/). *Brain*. [Basic Science / Preclinical]
Ivarola P (2024). [PMID: 38959649](https://pubmed.ncbi.nlm.nih.gov/38959649/). *Pediatr Neurol*. [Epidemiology / Natural History]